Multiple Ascending Dose Study of HU6 in High BMI Volunteers
Status:
Completed
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
This is a 14-day multiple ascending dose trial in high BMI volunteers in up to 4 cohorts of
10 high BMI volunteers each consisting of 8 receiving HU6 and 2 receiving placebo. Upon
review of the safety and PK data, it may be decided to expand the current cohort size and/or
dose escalate to the next cohort. In addition, the sponsor may elect not to enroll all 4
cohorts based on safety and/or PK and/or PD data, or enlist an additional cohort at a higher
dose if deemed safe.